The researchers highlighted that psoriasis is a systemic condition linked to various comorbidities, emphasizing the ...

Researchers studied the relationship between 3 dermatological immune-mediated inflammatory diseases and COVID-19.

In the treatment of psoriasis, preliminary evidence supports the hypothesis that IL-23 inhibitors are capable of extended remissions and protection against PsA relative to other biologics.

Overall, the study’s findings support the use of Amjevita and Imraldi as equally effective alternatives to Humira in the real ...

Discuss your feelings about the disease with your family ... With psoriasis, slow and steady wins the race. Psoriasis is a chronic skin condition, and while there is no known cure, there are ...

The annual meeting of the American Academy of Dermatology was held from March 7 to 11 in Orlando, Florida, and attracted ...

A recent review highlights how the Mediterranean diet can reduce inflammation and improve outcomes for chronic skin ...

Beyond the surface of your skin, eczema, psoriasis and more can majorly impact your self image and intimate relationships.

IL-23, or IL-17 reduced serious infections, while tofacitinib increased infection risk, according to one study.

A systematic review revealed that patients with psoriasis have a significantly higher prevalence of onychomycosis than those without psoriasis.

The following is a summary of “Completed suicide in patients with skin disease: A systematic review and meta-analysis,” ...

Join Drs Steven Feldman and Robert Kushner as they discuss the role of dermatologists in treating obesity in conjunction with psoriasis.